SAN DIEGO, May 4, 2011 /PRNewswire/ — Arena Pharmaceuticals,
Inc. (NASDAQ:
ARNA) today announced it will report first quarter 2011
financial results after the NASDAQ Global Select Market closes on
Tuesday, May 10, 2011. That same afternoon, Jack Lief, Arena’s
President and Chief Executive Officer, will host a conference call
and webcast at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to
discuss the financial results for the first quarter 2011 and to
provide a business and financial update.
The conference call may be accessed by dialing 877.643.7155 for
domestic callers and 914.495.8552 for international callers. Please
specify to the operator that you would like to join the “Arena
Pharmaceuticals’ First Quarter 2011 Financial Results Call.” The
conference call will be webcast live under the investor relations
section of Arena’s website at www.arenapharm.com, and will
be archived there for 30 days following the call. Please connect to
Arena’s website several minutes prior to the start of the broadcast
to ensure adequate time for any software download that may be
necessary.
About Arena PharmaceuticalsArena is a clinical-stage
biopharmaceutical company focused on discovering, developing and
commercializing oral drugs that target G protein-coupled receptors,
an important class of validated drug targets, in four major
therapeutic areas: cardiovascular, central nervous system,
inflammatory and metabolic diseases. Arena’s most advanced drug
candidate, lorcaserin, is intended for weight management. Arena’s
wholly owned subsidiary, Arena Pharmaceuticals GmbH, has granted
Eisai Inc. exclusive rights to market and distribute lorcaserin in
the United States subject to FDA approval of the New Drug
Application (NDA) for lorcaserin.
Arena Pharmaceuticals® and Arena® are registered
service marks of the company.
<
‘/>”/>
SOURCE